MCMCB Pro
J0712

J0712Injection, ceftaroline fosamil, 10 mg

HCPCSActiveBETOS O1E

J0712 is a HCPCS Level II code for injection, ceftaroline fosamil, 10 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J0712 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
120 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
outpatient
180 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
DME supplier
0 — never payable
MAI 3 — Date of Service Edit: Clinical · CMS Policy

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J0712

Long descriptor
Injection, ceftaroline fosamil, 10 mg

The official wording. This is what the code means.

Short descriptor
Ceftaroline fosamil inj

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2012

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J0712

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0712 is not quite right, the correct code is very often within a few positions of it.

  • J0697Injection, sterile cefuroxime sodium, per 750 mg
  • J0698Injection, cefotaxime sodium, per gm
  • J0699Injection, cefiderocol, 10 mg
  • J0701Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
  • J0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
  • J0703Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
  • J0706Injection, caffeine citrate, 5 mg
  • J0710Injection, cephapirin sodium, up to 1 gmterminated
  • J0713Injection, ceftazidime, per 500 mg
  • J0714Injection, ceftazidime and avibactam, 0.5 g/0.125 g
  • J0715Injection, ceftizoxime sodium, per 500 mgterminated
  • J0716Injection, centruroides immune f(ab)2, up to 120 milligrams
  • J0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J0720Injection, chloramphenicol sodium succinate, up to 1 gm
  • J0725Injection, chorionic gonadotropin, per 1,000 usp units
  • J0735Injection, clonidine hydrochloride, 1 mg

Questions about J0712

What is HCPCS code J0712?

J0712 is a HCPCS Level II code for injection, ceftaroline fosamil, 10 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J0712?

The CMS HCPCS file marks J0712 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J0712 paid under the physician fee schedule?

J0712 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026